TriangleMetronidazole (NCT06569368)
Metronidazole trial for Rectal Adenocarcinoma (NCT06569368). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with locally advanced rectal adenocarcinoma planned for total neoadjuvant therapy. They must not have received chemotherapy for this tumor; unresectable disease is excluded.
The idea: test whether adding metronidazole reduces bacteria within rectal cancers. Randomized groups receive standard treatment alone or with oral metronidazole every eight hours for two weeks. Researchers assess bacteria, tumor response and safety. Both groups continue treatment selected by their doctor. Benefit remains unestablished.
This phase 2 study plans 60 patients. Michael White leads MD Anderson's recruiting Houston site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.